Clinical Trial Update: Panobinostat Biological Correlates Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating panobinostat with biological correlates in various lymphoma conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma in Leukemic Phase
• Lymphoma with Cutaneous Involvement
• Marrow Involvement with Lymphoma
• Multiple Myeloma
• Nodal Lymphoma

Drugs mentioned

• Panobinostat (Panobinostat)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Nodal Lymphoma, Lymphoma With Cutaneous Involvement | Phase 2 | Status: COMPLETED